目的:观察药物联合超短波治疗小儿支原体肺炎的临床疗效及安全性.方法:将支原体肺炎患儿64 例,随机分为观察组34 例,对照组30 例,对照组采用阿奇霉素治疗,观察组在对照组的基础上超短波辅助治疗,比较2 组患儿临床疗效.结果:2 个疗程后观察组有效率为97.06%,对照组为83.33%,差异有统计学意义(P＜0.01);咳嗽缓解时间观察组为(5.21±1.39)天,对照组为(6.53±1.57)天,差异有统计学意义(P＜0.01).结论:肺部超短波辅助治疗小儿支原体肺炎疗效确切,能缩短疗程.%Objective: To explore curative effects and safety of medicine combined with ultrashort wave for infant mycoplasma pneumonia. Method: Sixty-four infants were randomly divided into 34 cases in observation group and 30 cases in control group. Control group were given with azithromycin and observation group with ultrashort wave. Clinical effects of both groups were compared. Result: After two courses of treatment, effective rate of observation group was 97.06%, higher than 83.33% of control group with statistical meaning (P<0.01); time of alleviating cough of observation group was (5.21 ±1.39) days, shorter than (6.53±1.57) days with statistical meaning(P<0.01). Conclusion: Pulmonary ultrashort wave is effective for infant mycoplasma pneumonia, which could shorten the length of course.
展开▼
